vimarsana.com

Page 12 - விஞ்ஞானிகள் இல் ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Single dose of Astrazenca, Pfizer vaccines cut COVID infection rate significantly, confirms study

New malaria breakthrough: Oxford vaccine shows high efficacy

The team behind the Oxford/AstraZeneca Covid-19 vaccine has developed the first jab against the mosquito-born disease to show more than 75 per cent efficacy.  OXFORD researchers have developed the world’s most effective malaria vaccine. The team behind the Oxford/AstraZeneca Covid-19 vaccine has developed the first jab against the mosquito-born disease to show more than 75 per cent efficacy.  Scientists at Oxford University have published preliminary results from a trial with 450 children, aged five to 17 months, who were split into three groups, with the first two groups receiving either a low dose or a high dose of the vaccine candidate.

The Latest: India sets global daily record of 332,730 cases

The Latest: EU agency: Get 2nd dose of AstraZeneca shots The Associated Press FacebookTwitterEmail 24 1of24FILE - In this Wednesday, April 14, 2021 file photo, a box with vials of AstraZeneca vaccine against COVID-19 were taken out of a fridge for a few seconds during a vaccination campaign in Amsterdam, Netherlands, . The European Medicines Agency is expected to provide updated guidance Friday April 23, 2021, on how countries across Europe should use the coronavirus vaccine developed by AstraZeneca.Peter Dejong/APShow MoreShow Less 2of24European Commission President Ursula von der Leyen, second left, speaks with Pfizer CEO Albert Bourla, center right, during an official visit to the Pfizer pharmaceutical company in Puurs, Belgium, Friday, April 23, 2021. (John Thys, Pool via AP)John Thys/APShow MoreShow Less

The Latest: More data confirm single dose of 2 vaccines work

The Latest: More data confirm single dose of 2 vaccines work by The Associated Press Last Updated Apr 23, 2021 at 4:14 am EDT LONDON Scientists at Oxford University have released more data that confirm coronavirus vaccines made by Pfizer-BioNTech and AstraZeneca both significantly cut the risk of infection after a single dose. In studies published on Friday, researchers said there was no apparent difference in the vaccines’ ability to reduce COVID-19 infection rates. The research has not yet been published in a peer-reviewed journal but is based on data from nose and throat swabs taken from more than 370,000 participants in England and Wales between December and April.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.